Validity of CureVac patent EP 1 857 122 B1 denied by German Federal Patent Court after nullity action filed by…
NAPOLEONVILLE, LA / ACCESSWIRE / December 19, 2023 / Marc Walther, CEO of IFUS (OTC PINK:IFUS) recently coined the phrase,…
BETHESDA, MD / ACCESSWIRE / December 19, 2023 / Get Well, the global leader in consumer digital patient engagement, announced…
NORTHAMPTON, MA / ACCESSWIRE / December 19, 2023 / We're proud to have contributed to this milestone announced by the…
LOS ANGELES--(BUSINESS WIRE)--mPulse, a leader in conversational AI and digital engagement solutions for the healthcare industry, today announced the acquisition…
Proceeds will fund Phase 2 study in thyroid eye disease (TED) with LASN01 and continue development of LASN500 in Investigational…
Dr. Beena Ahmed appointed vice president of Conferences Dr. Natalie Mrachacz-Kersting appointed vice president of Member and Student Activities Two-year…
TORONTO, ON / ACCESSWIRE / December 19, 2023 / Optimind Pharma Corp. (CSE:OMND) ("Optimind" or the "Company"), an emerging provider…
Three-year designation demonstrates company’s adherence to rigorous standards of quality and safety that drive better health outcomesMCLEAN, Va., Dec. 19,…
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) CARDIFF, United Kingdom, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX),…